107437-25-2

Basic information

• Product Name: methyl <1S-<1α,2α(Z),3α,4α>>-7-<3-<(tosyloxy)methyl>-7-oxabicyclo<2.2.1>hept-2-yl>-5-heptanoate
• Synonyms: methyl <1S-<1α,2α(Z),3α,4α>>-7-<3-<(tosyloxy)methyl>-7-oxabicyclo<2.2.1>hept-2-yl>-5-heptanoate
• CAS NO: 107437-25-2
• Molecular Weight: 422.543
• Mol File: 107437-25-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: methyl <1S-<1α,2α(Z),3α,4α>>-7-<3-<(tosyloxy)methyl>-7-oxabicyclo<2.2.1>hept-2-yl>-5-heptanoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl <1S-<1α,2α(Z),3α,4α>>-7-<3-<(tosyloxy)methyl>-7-oxabicyclo<2.2.1>hept-2-yl>-5-heptanoate(107437-25-2)
• EPA Substance Registry System: methyl <1S-<1α,2α(Z),3α,4α>>-7-<3-<(tosyloxy)methyl>-7-oxabicyclo<2.2.1>hept-2-yl>-5-heptanoate(107437-25-2)

Safety Data

• Hazardous Substances Data: 107437-25-2(Hazardous Substances Data)

Upstream product

• 98-59-9 p-toluenesulfonyl chloride 
• 94903-79-4 [1S-[1α,2α(5Z),3α,4α]]-7-[3-(hydroxymethyl)-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid, methyl ester 

Downstream Products

• 110106-62-2 (Z)-7-((1S,2R,3R,4R)-3-{[2-(4-Methoxy-phenylamino)-acetylamino]-methyl}-7-oxa-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid 
• 107332-47-8 [1S-[1α,2α(Z),3α,4α]]-7-[3-[[[[(1-oxoheptyl)amino]acetyl]amino]methyl]-7-oxabicyclo[2.2.1] hept-2-yl]-5-heptenoic acid 
• 128781-25-9 (Z)-7-[(1S,2R,3R,4R)-3-({2-[2-(4-tert-Butyl-phenylsulfanyl)-acetylamino]-acetylamino}-methyl)-7-oxa-bicyclo[2.2.1]hept-2-yl]-hept-5-enoic acid 
• 107511-79-5 (Z)-7-((1S,2R,3R,4R)-3-{[2-(2-Phenylsulfanyl-acetylamino)-acetylamino]-methyl}-7-oxa-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid methyl ester 
• 107511-90-0 (Z)-7-((1S,2R,3R,4R)-3-{[2-(4-Cyclohexyl-butyrylamino)-acetylamino]-methyl}-7-oxa-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid methyl ester 
• 128781-26-0 (Z)-7-((1S,2R,3R,4R)-3-{[2-(5-Cyclohexyl-pentanoylamino)-acetylamino]-methyl}-7-oxa-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid 
• 107511-78-4 (Z)-7-((1S,2R,3R,4R)-3-{[2-(2-Phenylsulfanyl-acetylamino)-acetylamino]-methyl}-7-oxa-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid 
• 107511-89-7 SQ 31491 
• 110106-61-1 (Z)-7-((1S,2R,3R,4R)-3-{[2-(4-Methoxy-phenylamino)-acetylamino]-methyl}-7-oxa-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid methyl ester 
• 128781-22-6 (Z)-7-((1S,2R,3R,4R)-3-{[2-(4-Methoxy-phenylsulfanyl)-acetylamino]-methyl}-7-oxa-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid 
• 128781-24-8 (Z)-7-{(1S,2R,3R,4R)-3-[(2-Benzoylamino-acetylamino)-methyl]-7-oxa-bicyclo[2.2.1]hept-2-yl}-hept-5-enoic acid 
• 119694-92-7 <1S-<1α,2α(Z),3α,4α>>-7-<3-<(Phenylthio)methyl>-7-oxabicyclo<2.2.1>hept-2-yl>-5-heptenoic acid 

Relevant articles and documents

9,11-Epoxy-9-homo-14-thiaprost-5-enoic Acid Derivatives: Potent Thromboxane A2 Antagonists

A novel bicyclic prostaglandine analogue, (1S)--7--7-oxabicyclohept-2-yl>-5-heptenoic acid ((-)10), and its congeners were found to be potent antagonists at the TxA2 receptor.Compound (-)-10 was the only stereo

7-Oxabicycloheptane substituted thio prostaglandin analogs and their use in the treatment of thrombolytic disease

7-Oxabicycloheptane substituted thio prostaglandin analogs are provided having the structural formula STR1 wherein R is hydrogen, lower alkyl or alkali metal, R1 is lower alkyl, arylalkyl, aryl, cycloalkyl or cycloalkylalkyl, X is O, S or NH, A is --CH=CH-- or --(CH2)2, p is 0 to 4, n is 1 to 4, n' is 0 to 2, q is 1 to 4 and m is 0 to 8, and including all stereoisomers thereof. The compounds are cardiovascular agents useful, for example, in the treatment of thrombolytic disease; and are antiinflammatory agents useful, for example, in the treatment of rheumatoid arthritis.